With Lee & Ko’s extensive expertise in representing both foreign and Korean multinationals, the firm is highly regarded for its work in sectors such as semiconductors, high-tech, finance, automotive, pharmaceuticals, shipping, and ICT. The team includes in-house economists, former KFTC officials, lawyers, and ex-judges and prosecutors, providing comprehensive competition law services. Co-headed by Hwan Jeong, who specialises in merger control, cartels, abuse of dominance, and antitrust litigation, and Jeong-Ho Sun, who is known for handling significant cartel cases and international merger filings. Jungwon Kwon offers a wealth of experience advising multinational corporations on merger control, cartel issues, and antitrust litigation. Suruyn Kim is noted for navigating complex merger reviews, while Jeong Yoon Choi has extensive experience with international cartels, M&A, and KFTC investigations.
Legal 500 redaktioneller Kommentar
- Profil
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘I highly recommend the antitrust and competition team at Lee & Ko for their exceptional legal services. Their deep expertise in competition law, client-focused approach, and strategic insights have been invaluable to us.'
‘I highly recommend Miji Lee, an antitrust & competition lawyer at Lee & Ko. Miji Lee has provided us with exceptional legal support, demonstrating deep expertise and a meticulous approach to every detail. What truly sets Miji Lee apart is her attentiveness and dedication to our needs. She consistently goes above and beyond to ensure we are well informed and supported throughout our legal processes. Her proactive communication and thoughtful guidance have been invaluable.'
‘Lee & Ko's anti-trust team is incredibly responsive and speedy. On top of that, their team members have diverse backgrounds, such as PhD, ex-agency officers, and tech professionals.’
‘Jeong-Ho Sun is a dedicated partner in the anti-trust area, with years of experience and good networks in the industry.’
‘The team of professional lawyers specialising in fair trade work can be said to be the strongest in South Korea. It has an excellent ability to present comprehensive strategies and response plans by establishing organic cooperative relationships with professional teams in each industry.’
‘They have expertise in the field, and the team has the ability to spot key issues that clients might not be aware of.’
‘Lee & Ko is not only known for its long history of providing superb legal service, but it is also a trusted advisor devoted to true communication with clients. Lee & Ko attorneys are great communicators in that they sincerely commit to understanding the business needs and environment.’
'Jeong Yoon Choi is an excellent antitrust lawyer. Her willingness to commit to different time zones and respond timely according to client needs has been very impressive. Jeong Yoon approaches a given subject not only from a legal perspective but from the client\'s unique situation and other non-legal circumstances, which is not something that every other lawyer can do.'
Kernmandanten
- Novozymes A/S
- Tapestry Inc.
- Stratasys Ltd., Stratasys AP Ltd., Stratasys Korea Limited
- Korean Bar Association, Seoul Bar Association
- LG Chem Co. Ltd.
- NAVER Corporation
- Dechra
- Wanhai
- SK Telecom, KT, LG UPlus, Korea Credit Bureau, Seoul Guarantee Insurance Company
- Aurelius Group
Highlight-Mandate
Represented Novozymes in the merger filing for Novozymes’ merger with Chr. Hansen (a large-scale statutory merger between the largest global biotechnology companies of Denmark) and successfully obtained unconditional clearance of the USD 12.3 billion transaction from the KFTC.
Represented T-Way, Korea’s leading low-cost carrier, in the European Commission’s merger review process in its bid to become the remedy taker for passenger flights in the large global merger (valued at USD 1.34 billion) between Korean Air and Asiana Airlines.
Represented Alvogen after the KFTC commenced an investigation on the collusion between Alvogen and AstraZeneca Korea Ltd., alleging that Alvogen delayed the development of the generic versions of AstraZeneca’s original drugs (Zoladex, Arimidex and Casodex (“DEX drugs”)) in exchange for exclusive distribution rights to DEX drugs in South Korea.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Partner*innen der nächsten Generation
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Führende Associates
Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.
Praxisleitung
Hwan Jeong; Jeong-Ho Sun
Weitere Kernanwält*innen
Suruyn Kim; Jungwon Kwon; Yong Seok Ahn; Miji Lee; Jong Youn Han; Byong Ki Chung; Frank Shyn; Jeong Yoon Choi